Report Detail

Other Global and United States Leukapheresis Market Size, Status and Forecast 2020-2026

  • RnM4207046
  • |
  • 15 September, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Leukapheresis Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Apheresis Machine
    • 1.2.3 Leukocyte Filter
    • 1.2.4 Column
    • 1.2.5 Disposables
  • 1.3 Market by Application
    • 1.3.1 Global Leukapheresis Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Research Institute
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Leukapheresis Market Perspective (2015-2026)
  • 2.2 Global Leukapheresis Growth Trends by Regions
    • 2.2.1 Leukapheresis Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Leukapheresis Historic Market Share by Regions (2015-2020)
    • 2.2.3 Leukapheresis Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Leukapheresis Players by Market Size
    • 3.1.1 Global Top Leukapheresis Players by Revenue (2015-2020)
    • 3.1.2 Global Leukapheresis Revenue Market Share by Players (2015-2020)
  • 3.2 Global Leukapheresis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Leukapheresis Revenue
  • 3.4 Global Leukapheresis Market Concentration Ratio
    • 3.4.1 Global Leukapheresis Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Leukapheresis Revenue in 2019
  • 3.5 Key Players Leukapheresis Area Served
  • 3.6 Key Players Leukapheresis Product Solution and Service
  • 3.7 Date of Enter into Leukapheresis Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Leukapheresis Breakdown Data by Type (2015-2026)

  • 4.1 Global Leukapheresis Historic Market Size by Type (2015-2020)
  • 4.2 Global Leukapheresis Forecasted Market Size by Type (2021-2026)

5 Leukapheresis Breakdown Data by Application (2015-2026)

  • 5.1 Global Leukapheresis Historic Market Size by Application (2015-2020)
  • 5.2 Global Leukapheresis Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Leukapheresis Market Size (2015-2026)
  • 6.2 North America Leukapheresis Market Size by Type (2015-2020)
  • 6.3 North America Leukapheresis Market Size by Application (2015-2020)
  • 6.4 North America Leukapheresis Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Leukapheresis Market Size (2015-2026)
  • 7.2 Europe Leukapheresis Market Size by Type (2015-2020)
  • 7.3 Europe Leukapheresis Market Size by Application (2015-2020)
  • 7.4 Europe Leukapheresis Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Leukapheresis Market Size (2015-2026)
  • 8.2 China Leukapheresis Market Size by Type (2015-2020)
  • 8.3 China Leukapheresis Market Size by Application (2015-2020)
  • 8.4 China Leukapheresis Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Leukapheresis Market Size (2015-2026)
  • 9.2 Japan Leukapheresis Market Size by Type (2015-2020)
  • 9.3 Japan Leukapheresis Market Size by Application (2015-2020)
  • 9.4 Japan Leukapheresis Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Leukapheresis Market Size (2015-2026)
  • 10.2 Southeast Asia Leukapheresis Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Leukapheresis Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Leukapheresis Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Asahi Kasei Medical
    • 11.1.1 Asahi Kasei Medical Company Details
    • 11.1.2 Asahi Kasei Medical Business Overview
    • 11.1.3 Asahi Kasei Medical Leukapheresis Introduction
    • 11.1.4 Asahi Kasei Medical Revenue in Leukapheresis Business (2015-2020))
    • 11.1.5 Asahi Kasei Medical Recent Development
  • 11.2 Fresenius Se & Co. KGaA
    • 11.2.1 Fresenius Se & Co. KGaA Company Details
    • 11.2.2 Fresenius Se & Co. KGaA Business Overview
    • 11.2.3 Fresenius Se & Co. KGaA Leukapheresis Introduction
    • 11.2.4 Fresenius Se & Co. KGaA Revenue in Leukapheresis Business (2015-2020)
    • 11.2.5 Fresenius Se & Co. KGaA Recent Development
  • 11.3 Haemonetics Corporation
    • 11.3.1 Haemonetics Corporation Company Details
    • 11.3.2 Haemonetics Corporation Business Overview
    • 11.3.3 Haemonetics Corporation Leukapheresis Introduction
    • 11.3.4 Haemonetics Corporation Revenue in Leukapheresis Business (2015-2020)
    • 11.3.5 Haemonetics Corporation Recent Development
  • 11.4 Hemacare Corporation
    • 11.4.1 Hemacare Corporation Company Details
    • 11.4.2 Hemacare Corporation Business Overview
    • 11.4.3 Hemacare Corporation Leukapheresis Introduction
    • 11.4.4 Hemacare Corporation Revenue in Leukapheresis Business (2015-2020)
    • 11.4.5 Hemacare Corporation Recent Development
  • 11.5 Key Biologics, LLC.
    • 11.5.1 Key Biologics, LLC. Company Details
    • 11.5.2 Key Biologics, LLC. Business Overview
    • 11.5.3 Key Biologics, LLC. Leukapheresis Introduction
    • 11.5.4 Key Biologics, LLC. Revenue in Leukapheresis Business (2015-2020)
    • 11.5.5 Key Biologics, LLC. Recent Development
  • 11.6 Terumo BCT
    • 11.6.1 Terumo BCT Company Details
    • 11.6.2 Terumo BCT Business Overview
    • 11.6.3 Terumo BCT Leukapheresis Introduction
    • 11.6.4 Terumo BCT Revenue in Leukapheresis Business (2015-2020)
    • 11.6.5 Terumo BCT Recent Development
  • 11.7 ALLCells, LLC.
    • 11.7.1 ALLCells, LLC. Company Details
    • 11.7.2 ALLCells, LLC. Business Overview
    • 11.7.3 ALLCells, LLC. Leukapheresis Introduction
    • 11.7.4 ALLCells, LLC. Revenue in Leukapheresis Business (2015-2020)
    • 11.7.5 ALLCells, LLC. Recent Development
  • 11.8 Stemexpress, LLC.
    • 11.8.1 Stemexpress, LLC. Company Details
    • 11.8.2 Stemexpress, LLC. Business Overview
    • 11.8.3 Stemexpress, LLC. Leukapheresis Introduction
    • 11.8.4 Stemexpress, LLC. Revenue in Leukapheresis Business (2015-2020)
    • 11.8.5 Stemexpress, LLC. Recent Development
  • 11.9 Stemcell Technologies, Inc.
    • 11.9.1 Stemcell Technologies, Inc. Company Details
    • 11.9.2 Stemcell Technologies, Inc. Business Overview
    • 11.9.3 Stemcell Technologies, Inc. Leukapheresis Introduction
    • 11.9.4 Stemcell Technologies, Inc. Revenue in Leukapheresis Business (2015-2020)
    • 11.9.5 Stemcell Technologies, Inc. Recent Development
  • 11.10 Caltag Medsystems Limited
    • 11.10.1 Caltag Medsystems Limited Company Details
    • 11.10.2 Caltag Medsystems Limited Business Overview
    • 11.10.3 Caltag Medsystems Limited Leukapheresis Introduction
    • 11.10.4 Caltag Medsystems Limited Revenue in Leukapheresis Business (2015-2020)
    • 11.10.5 Caltag Medsystems Limited Recent Development
  • 11.11 Zenbio, Inc.
    • 10.11.1 Zenbio, Inc. Company Details
    • 10.11.2 Zenbio, Inc. Business Overview
    • 10.11.3 Zenbio, Inc. Leukapheresis Introduction
    • 10.11.4 Zenbio, Inc. Revenue in Leukapheresis Business (2015-2020)
    • 10.11.5 Zenbio, Inc. Recent Development
  • 11.12 Precision for Medicine, Inc.
    • 10.12.1 Precision for Medicine, Inc. Company Details
    • 10.12.2 Precision for Medicine, Inc. Business Overview
    • 10.12.3 Precision for Medicine, Inc. Leukapheresis Introduction
    • 10.12.4 Precision for Medicine, Inc. Revenue in Leukapheresis Business (2015-2020)
    • 10.12.5 Precision for Medicine, Inc. Recent Development
  • 11.13 PPA Research Group, Inc.
    • 10.13.1 PPA Research Group, Inc. Company Details
    • 10.13.2 PPA Research Group, Inc. Business Overview
    • 10.13.3 PPA Research Group, Inc. Leukapheresis Introduction
    • 10.13.4 PPA Research Group, Inc. Revenue in Leukapheresis Business (2015-2020)
    • 10.13.5 PPA Research Group, Inc. Recent Development
  • 11.14 Bioivt
    • 10.14.1 Bioivt Company Details
    • 10.14.2 Bioivt Business Overview
    • 10.14.3 Bioivt Leukapheresis Introduction
    • 10.14.4 Bioivt Revenue in Leukapheresis Business (2015-2020)
    • 10.14.5 Bioivt Recent Development
  • 11.15 Macopharma SA
    • 10.15.1 Macopharma SA Company Details
    • 10.15.2 Macopharma SA Business Overview
    • 10.15.3 Macopharma SA Leukapheresis Introduction
    • 10.15.4 Macopharma SA Revenue in Leukapheresis Business (2015-2020)
    • 10.15.5 Macopharma SA Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Leukapheresis Scope and Market Size
    Leukapheresis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leukapheresis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Apheresis Machine
    Leukocyte Filter
    Column
    Disposables

    Market segment by Application, split into
    Hospitals
    Research Institute

    Based on regional and country-level analysis, the Leukapheresis market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Leukapheresis market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Asahi Kasei Medical
    Fresenius Se & Co. KGaA
    Haemonetics Corporation
    Hemacare Corporation
    Key Biologics, LLC.
    Terumo BCT
    ALLCells, LLC.
    Stemexpress, LLC.
    Stemcell Technologies, Inc.
    Caltag Medsystems Limited
    Zenbio, Inc.
    Precision for Medicine, Inc.
    PPA Research Group, Inc.
    Bioivt
    Macopharma SA


    Summary:
    Get latest Market Research Reports on Leukapheresis. Industry analysis & Market Report on Leukapheresis is a syndicated market report, published as Global and United States Leukapheresis Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Leukapheresis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,010.96
    4,516.44
    6,021.92
    3,292.78
    4,939.17
    6,585.56
    407,429.10
    611,143.65
    814,858.20
    286,697.19
    430,045.79
    573,394.38
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report